✦ LIBER ✦

96 Chemotherapy in advanced NSCLC: Randomised comparison of ifosfamid/vindesin versus mitomycin/ifosfamid/cisplatin: A preliminary report

✍ Scribed by Serke, M.; Riedel, U.; Schoenfeld, N.; Loddenkemper, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

71 Chemotherapy in advanced NSCLC: Rando

✍ Serke, M.; Riedel, U.; Schoenfeld, N.; Loddenkemper, R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Chemotherapy in advanced NSCLC: Randomiz

✍ Serke, M; Rücker, M; Riedel, U; Schoenfeld, N; Loddenkemper, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A phase II/III randomised comparison of

✍ Rudd, R.M; Gower, N.H; James, L.E; Gregory, W; Eisen, T.Q; Lee, S.M; Harper, P.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

PD-086 A phase II randomised study of ge

✍ Brechot, J.; Saintigny, P.; Azorin, J.; Valeyre, D.; Breau, J.; Morere, J.; Gnom 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemcitabine monotherapy (GEM) versus cis

✍ Vansteenkiste, J; Vandebroek, J; Nackaerts, K; Deschepper, K; Van Kerckhoven, W; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

O-095 A phase III trial of docetaxel/car

✍ Lorigan, P. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB